compounding of semaglutide The Risks Compounded Products Semaglutide - PremierHealthMD

Healio: What do we know about the impact of GLP-1 receptor agonists in pregnancy , and what research still needs to be conducted

It is especially relevant for patients taking or researching semaglutide, tirzepatide, GLP-1 injections, oral GLP-1 options, or physician-supervised weight loss programs

Multiple factors unrelated to the medication may cause respiratory symptoms, including underlying cardiovascular disease, obesity-related conditions like sleep apnea, worsening GERD from delayed gastric emptying, anxiety or panic attacks, concurrent medications affecting breathing, or unrelated respiratory infections

Even at low doses, muscle loss, nutritional deficiencies, and rebound weight gain remain possible if not paired with supportive strategies like: In short, microdosing Ozempic is an emerging and somewhat experimental approach